Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
AIDS ; 27 Suppl 2: S215-24, 2013 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24361631

RESUMO

Treatment 2.0 is an initiative launched by UNAIDS and WHO in 2011 to catalyze the next phase of treatment scale-up for HIV. The initiative defines strategic activities in 5 key areas, drugs, diagnostics, commodity costs, service delivery and community engagement in an effort to simplify treatment, expand access and maximize program efficiency. For adults, many of these activities have already been turned into treatment policies. The recent WHO recommendation to use a universal first line regimen regardless of gender, pregnancy and TB status is a treatment simplification very much in line with Treatment 2.0. But despite that fact that Treatment 2.0 encompasses all people living with HIV, we have not seen the same evolution in policy development for children. In this paper we discuss how Treatment 2.0 principles can be adapted for the pediatric population. There are several intrinsic challenges. The need for distinct treatment regimens in children of different ages makes it hard to define a one size fits all approach. In addition, the fact that many providers are reluctant to treat children without the advice of specialists can hamper decentralization of service delivery. But at the same time, there are opportunities that can be availed now and in the future to scale up pediatric treatment along the lines of Treatment 2.0. We examine each of the five pillars of Treatment 2.0 from a pediatric perspective and present eight specific action points that would result in simplification of pediatric treatment and scale up of HIV services for children.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Assistência Integral à Saúde , Infecções por HIV , Transmissão Vertical de Doenças Infecciosas/prevenção & controle , Pediatria/normas , Adulto , Fármacos Anti-HIV/economia , Criança , Análise Custo-Benefício , Prestação Integrada de Cuidados de Saúde , Indústria Farmacêutica/economia , Feminino , Saúde Global , Infecções por HIV/diagnóstico , Infecções por HIV/tratamento farmacológico , Infecções por HIV/economia , Infecções por HIV/transmissão , Necessidades e Demandas de Serviços de Saúde , Humanos , Lactente , Recém-Nascido , Pediatria/educação , Gravidez , Desenvolvimento de Programas , Organização Mundial da Saúde
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...